Importance of soluble cytokine receptors for inflammation associated cancer
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 8
Abstract
Cytokine receptors, which exist in membrane-bound and soluble form, bind their ligands with comparable affinity. While most soluble receptors are antagonists in that they compete for the ligands with their membrane counterparts, some soluble receptors are agonists. In this case, the complex of ligand and soluble receptor binds on target cells to a second receptor subunit and initiates signal transduction. The soluble receptors of the IL-6 family of cytokines (sIL-6R, sIL-11R, sCNTF-R) are agonists. In vivo, the IL-6/soluble IL-6R complex stimulates several types of target cells not stimulated by IL-6 alone, since they do not express membrane-bound IL-6R. This process has been named transsignalling. We have shown that in several chronic inflammatory diseases such as chronic inflammatory bowl disease, peritonitis and rheumatoid arthritis, transsignalling via soluble IL-6R complexed to IL-6 is a crucial point in the transition from the acute to the chronic state of the disease. The mechanism by which the IL-6/ soluble IL-6R complex regulates the inflammatory state is discussed.
Authors and Affiliations
Stefan Rose-John
Targeted therapy of colorectal cancer - state of the art
The recent development of drugs that target the key components of biologic pathways rendered an improvement in survival in colorectal cancer patients. Two monoclonal antibodies in particular, targeting vascular endotheli...
Postępy w leczeniu wczesnego raka piersi – najważniejsze doniesienia z 2005 r. – sprawozdanie z konferencji
Rola IMRT w redukcji dawki promieniowania w odbytnicy w trakcie radykalnej radioterapii raka gruczołu krokowego
Cel pracy: Celem pracy było porównanie dwóch technik napromieniania raka gruczołu krokowego – IMRT vs 3D- -CRT – pod względem dawek zdeponowanych w odbytnicy. Materiał i metody: W badaniu wykorzystano dane (przekroje t...
Nowotworowy prokoagulant (CP) w chirurgicznej diagnostyce onkologicznej
Znaczne zaawansowanie procesu nowotworowego w chwili podjęcia leczenia jest główną przyczyną wysokiej umieralności z powodu nowotworów złośliwych. Wykrycie nowotworu w stadium jak najwcześniejszym oraz podjęcie wczesnego...
Squamous cell carcinoma antigen (SCC) in diagnostics and monitoring treatment of patients with cervical cancer
Squamous cell carcinoma antigen (SCC) is the first marker of squamous cell carcinoma and a member of the serin proteinase inhibitor family. Increased concentration of SCC occurs in squamous cancers of the region of the h...